Pfizer’s Lyrica Is “Approvable” At FDA
Neurontin follow-on drug pregabalin receives second “approvable” decision in two months. Pfizer is looking to convert Neurontin patients to the successor product in the face of gabapentin generics.
Neurontin follow-on drug pregabalin receives second “approvable” decision in two months. Pfizer is looking to convert Neurontin patients to the successor product in the face of gabapentin generics.